Fioricet Butalbital Migraine Relief Usa - Story
Many of the people who were taking those drugs would have been far safer, in fact many would be alive today, if they had been taking over-the-counter non-steroidal anti-inflammatory drugs instead. Wouldn't it seem that consumers have no influence whatsoever on the success of a prescription drug, so advertising should be directed entirely toward doctors. Fillon writes, "The average number of prescriptions per person in the United States increased from 7. That's how pharmaceutical commercials really work. They directly influence consumer behavior, yet drug companies claim they only "educate" patients, but don't persuade them to do anything. By 1995 drug companies had tripled the amount of money allotted to direct advertising of prescription drugs to consumers. Over the next 11 years, this increased more than 50-fold to over $3 billion in 2003. Why.9 percent of all lipid-lowering prescriptions.75 million on testing. At pharmaceutical companies, doctors usually don't make the final decisions—business people make them. Herbal Defense by Ralph T Golan ND, page 210 Anyone who watches television cannot but help notice a new trend in the past couple of years — suddenly our TV programs are flooded with advertisements for dozens of new prescription drugs. Drug companies know that putting sophisticated detailing teams in the field to promote their products to doctors makes a difference in prescribing behavior., page 91 Drug companies often claim that they are just helping the public by providing physicians the best information possible." On The Take by Jerome P Kassirer M. Prozac Backlash by Joseph Glenmullen MD, page 232 For years the pharmaceutical industry was allowed to market its drugs only to doctors. But the rules were strict, and the content of the ads was, therefore, limited: Drugs could be mentioned by name, but advertisements that discussed the treatment of specific conditions were required to include a lengthy list of side effects and contraindications (situations in which the drug should not be used).